The markets advanced during the midday with the Dow soaring 158 points to 17,133 as the nation’s trade deficit narrowed. Nasdaq added 5 points to 4,554.
On the upside
The Center for Medicare & Medicaid Services granted transitional pass-through status to Omeros (Nasdaq: OMER) for its Omidria.
Abiomed (Nasdaq: ABMD) reported sharply higher second quarter earnings that more than tripled to top analyst estimates.
Calix (NYSE: CALX) fell to a loss for the third quarter but the results were better than expected.
On the downside
Yamana Gold (NYSE: AUY) fell to a greater than expected loss for the third quarter.
Accuray (Nasdaq: ARAY) widened first quarter losses more than expected.
Parexel International (Nasdaq: PRXL) reported higher first quarter earnings but revenue missed expectations prompting a downgrade.
In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 5 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 gained 7 points to 1989. Bitcoin slipped $2 to $334.
